Tian An Medicare Limited has issued an offer document dated 28 April 2026 outlining a conditional cash offer to repurchase up to 70.00 million shares through Morton Securities Limited at HK$1.10 per share. If fully taken up, the maximum cash outlay would reach approximately HK$77.00 million.
\n\nKey terms • Maximum buy-back size: 70.00 million shares, representing an aggregate consideration of about HK$77.00 million. • Offer price: HK$1.10 per share, payable in cash. • Acceptance ratio: The actual number of shares repurchased from each accepting shareholder will be determined by a pro-rata formula described in the offer document. Fractions will not be purchased; holdings will be rounded to the nearest whole share at the company’s discretion. • Conditions: The offer will only proceed once the stated conditions become unconditional under the Codes on Takeovers and Share Buy-backs. No withdrawal of acceptances will be permitted after the offer becomes unconditional unless otherwise directed by the Executive.
\n\nTimetable and procedures • Latest acceptance time: 4:00 p.m. on Monday, 1 June 2026, unless extended in accordance with the Codes. • Accepting shareholders must deliver a completed Form of Acceptance and the relevant share certificates to Tricor Investor Services Limited, 17/F, Far East Finance Centre, 16 Harcourt Road, Hong Kong, in an envelope marked “Tian An Medicare Limited — Buy-back Offer.” • Shareholders will receive payment by cheque crossed “Not negotiable — account payee only” for the shares accepted and repurchased.
\n\nOther considerations • All shares tendered must be fully paid and free of liens or encumbrances. • Overseas shareholders are responsible for ensuring compliance with local regulations and for any taxes or duties arising from participation. • Personal data supplied in the Form of Acceptance will be used solely for processing the offer, maintaining shareholder records and related statutory or regulatory purposes.
\n\nThe offer provides shareholders an opportunity to realise cash at a fixed price of HK$1.10, subject to the pro-rata scaling mechanism and satisfaction of all conditions set out in the offer document.